← Leaderboards
Henry S. Friedman
Duke University
$12,588,060
Attributed
$12,588,060
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$12,588,060 · 10
By mechanism
T32$3,849,530 · 1
R01$3,838,306 · 2
P50$3,481,147 · 2
R21$798,400 · 2
U01$522,552 · 1
U19$98,125 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Oliver Michael Colvin$5,510,946
- Darell D Bigner$25,397,506
- Doris A Taylor$6,306,380
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaMedulloblastomaNeoplasm /Cancer ChemotherapyDrug ResistanceAthymic MouseHuman SubjectAntineoplasticsEnzyme ActivityDna RepairAnalogClinical ResearchMeningitisNeoplasm /Cancer TransplantationTemozolomideNonhuman Therapy EvaluationDrug Screening /EvaluationBrain NeoplasmsDisease /Disorder ModelClinical TrialsResearch TrainingNeuro-OncologyCarmustineCentral Nervous System NeoplasmsInfection Related Neoplasm /Cancer
Grant awards (50)
Research Training in Neuro-Oncology$346,009
T32 · FY2014 · CA · contact PI
Research Training in Neuro-Oncology$309,360
T32 · FY2013 · CA · contact PI
Research Training in Neuro-Oncology$360,612
T32 · FY2012 · CA · contact PI
Research Training in Neuro-Oncology$273,002
T32 · FY2011 · CA · contact PI
Research Training in Neuro-Oncology$361,985
T32 · FY2010 · CA · contact PI
Research Training In Neuro-Oncology$320,126
T32 · FY2009 · CA · contact PI
Research Training In Neuro-Oncology$306,040
T32 · FY2008 · CA · contact PI
Temodar Resistance in CNS Tumors$292,039
R01 · FY2008 · NS · contact PI
DNA Repair-Mediated BCNU Resistance in CNS Tumors$260,607
P50 · FY2008 · NS · contact PI
TEMODAR RESISTANCE IN CENTRAL NERVOUS SYSTEM$212,171
P50 · FY2008 · CA · contact PI
Temodar Resistance in CNS Tumors$292,039
R01 · FY2007 · NS · contact PI
DNA Repair-Mediated BCNU Resistance in CNS Tumors$268,417
P50 · FY2007 · NS · contact PI
TEMODAR RESISTANCE IN CENTRAL NERVOUS SYSTEM$222,962
P50 · FY2007 · CA · contact PI
Research Training In Neuro-Oncology$204,871
T32 · FY2007 · CA · contact PI
Research Training In Neuro-Oncology$305,378
T32 · FY2006 · CA · contact PI
Temodar Resistance in CNS Tumors$300,762
R01 · FY2006 · NS · contact PI
DNA Repair-Mediated BCNU Resistance in CNS Tumors$241,062
P50 · FY2006 · NS · contact PI
TEMODAR RESISTANCE IN CENTRAL NERVOUS SYSTEM$133,465
P50 · FY2006 · CA · contact PI
Research Training In Neuro-Oncology$390,414
T32 · FY2005 · CA
Regional AGT Depeltion of CNS and Leptomeningeal Tumors$308,385
R01 · FY2005 · CA
Temodar Resistance in CNS Tumors$308,000
R01 · FY2005 · NS
DNA Repair-Mediated BCNU Resistance in CNS Tumors$241,062
P50 · FY2005 · NS
TEMODAR RESISTANCE IN CENTRAL NERVOUS SYSTEM$133,469
P50 · FY2005 · CA
Regional AGT Depeltion of CNS and Leptomeningeal Tumors$308,385
R01 · FY2004 · CA
DNA Repair-Mediated BCNU Resistance in CNS Tumors$241,062
P50 · FY2004 · NS
RESEARCH TRAINING IN NEURO-ONCOLOGY$181,175
T32 · FY2004 · CA
TEMODAR RESISTANCE IN CENTRAL NERVOUS SYSTEM$133,603
P50 · FY2004 · CA
DNA REPAIR MEDIATED RESISTANCE IN CNS TUMORS$366,155
R01 · FY2003 · NS
Regional AGT Depeltion of CNS and Leptomeningeal Tumors$308,385
R01 · FY2003 · CA
PEDIATRIC BRAIN TUMOR CLINICAL TRIALS CONSORTIUM$133,898
U01 · FY2003 · CA
DNA REPAIR MEDIATED RESISTANCE IN CNS TUMORS$357,540
R01 · FY2002 · NS
ZD1839 Therapy of Glioblastoma Multiforme$322,200
R21 · FY2002 · CA
INTRATHECAL CAMPTOTHECIN ANALOGS FOR NEOPLASTIC MENINGITIS$313,976
P50 · FY2002 · NS
Regional AGT Depeltion of CNS and Leptomeningeal Tumors$308,385
R01 · FY2002 · CA
RESEARCH TRAINING IN NEURO-ONCOLOGY$198,610
T32 · FY2002 · CA
PEDIATRIC BRAIN TUMOR CLINICAL TRIALS CONSORTIUM$131,683
U01 · FY2002 · CA
DNA REPAIR MEDIATED BCNU RESISTANCE IN CNS TUMORS$0
P20 · FY2002 · CA
DNA REPAIR MEDIATED RESISTANCE IN CNS TUMORS$349,178
R01 · FY2001 · NS
ZD1839 Therapy of Glioblastoma Multiforme$322,200
R21 · FY2001 · CA
INTRATHECAL CAMPTOTHECIN ANALOGS FOR NEOPLASTIC MENINGITIS$313,976
P50 · FY2001 · NS
INTRATHECAL CAMPTOTHECIN ANALOGS FOR NEOPLASTIC MENINGITIS$288,255
P50 · FY2001 · NS
RESEARCH TRAINING IN NEURO-ONCOLOGY$183,066
T32 · FY2001 · CA
PEDIATRIC BRAIN TUMOR CLINICAL TRIALS CONSORTIUM$129,530
U01 · FY2001 · CA
DNA REPAIR MEDIATED RESISTANCE IN CNS TUMORS$339,053
R01 · FY2000 · NS
INTRATHECAL CAMPTOTHECIN ANALOGS FOR NEOPLASTIC MENINGITIS$288,255
P50 · FY2000 · NS
INTRATHECAL CAMPTOTHECIN ANALOGS FOR NEOPLASTIC MENINGITIS$188,805
P50 · FY2000 · NS
TEMOZOLOMIDE RESISTANCE IN CNS TUMORS$154,000
R21 · FY2000 · CA
PEDIATRIC BRAIN TUMOR CLINICAL TRIALS CONSORTIUM$127,441
U01 · FY2000 · CA
RESEARCH TRAINING IN NEURO-ONCOLOGY$108,882
T32 · FY2000 · CA
REGIONAL THERAPY WITH AGT INHIBITORS AND BCNU$98,125
U19 · FY2000 · CA